Michael L Alosco1, Mary Beth Spitznagel1, Gladys Strain2, Michael Devlin3, Ronald Cohen4, Ross D Crosby5, James E Mitchell5, John Gunstad6. 1. Kent State University, Kent, OH, United States. 2. Weill Cornell Medical College, New York, NY, United States. 3. Columbia University Medical Center, New York, NY, United States. 4. University of Florida Institute on Aging, Gainesville, FL, United States. 5. University of North Dakota School of Medicine and Health Sciences, Neuropsychiatric Research Institute, Fargo, ND, United States. 6. Kent State University, Kent, OH, United States. Electronic address: jgunstad@kent.edu.
Abstract
BACKGROUND: The mechanisms for improved cognitive function post-bariatric surgery are not well understood. Markers of kidney and liver function (i.e., cystatin C and alkaline phosphatase (ALP)) are elevated in obese individuals and associated with poor neurocognitive outcomes in other samples. Bariatric surgery can improve cystatin C and ALP levels, but no study has examined whether such changes correspond to post-operative cognitive benefits. METHODS: 78 bariatric surgery patients completed a computerized cognitive test battery prior to and 12-months after surgery. All participants underwent an eight-hour fasting blood draw to quantify cystatin C and ALP concentrations. RESULTS: Cognitive function improved after surgery. Cystatin C levels decreased at the 12-month follow-up; however, no changes were found in ALP concentrations. At baseline, higher cystatin C levels predicted worse attention/executive function, but no such effects emerged for ALP. Regression analyses controlling for possible medical and demographic confounds and baseline factors revealed that decreased ALP levels following surgery predicted better attention/executive function and memory abilities. Post-surgery changes in cystatin C did not correspond to cognitive improvements. CONCLUSIONS: Decreased ALP levels predicted better cognition following bariatric surgery, suggesting improved liver function as a possible mechanism of post-operative cognitive benefits. Future studies with neuroimaging and longer follow-up periods are needed to determine whether bariatric surgery can decrease risk for adverse brain changes and dementia in severely obese persons via improved metabolic function.
BACKGROUND: The mechanisms for improved cognitive function post-bariatric surgery are not well understood. Markers of kidney and liver function (i.e., cystatin C and alkaline phosphatase (ALP)) are elevated in obese individuals and associated with poor neurocognitive outcomes in other samples. Bariatric surgery can improve cystatin C and ALP levels, but no study has examined whether such changes correspond to post-operative cognitive benefits. METHODS: 78 bariatric surgery patients completed a computerized cognitive test battery prior to and 12-months after surgery. All participants underwent an eight-hour fasting blood draw to quantify cystatin C and ALP concentrations. RESULTS: Cognitive function improved after surgery. Cystatin C levels decreased at the 12-month follow-up; however, no changes were found in ALP concentrations. At baseline, higher cystatin C levels predicted worse attention/executive function, but no such effects emerged for ALP. Regression analyses controlling for possible medical and demographic confounds and baseline factors revealed that decreased ALP levels following surgery predicted better attention/executive function and memory abilities. Post-surgery changes in cystatin C did not correspond to cognitive improvements. CONCLUSIONS: Decreased ALP levels predicted better cognition following bariatric surgery, suggesting improved liver function as a possible mechanism of post-operative cognitive benefits. Future studies with neuroimaging and longer follow-up periods are needed to determine whether bariatric surgery can decrease risk for adverse brain changes and dementia in severely obesepersons via improved metabolic function.
Authors: Steven H Belle; Paul D Berk; Anita P Courcoulas; David R Flum; Carolyn W Miles; James E Mitchell; Walter J Pories; Bruce M Wolfe; Susan Z Yanovski Journal: Surg Obes Relat Dis Date: 2007 Mar-Apr Impact factor: 4.734
Authors: Jacob D Bolzenius; David H Laidlaw; Ryan P Cabeen; Thomas E Conturo; Amanda R McMichael; Elizabeth M Lane; Jodi M Heaps; Lauren E Salminen; Laurie M Baker; John Gunstad; Robert H Paul Journal: Brain Imaging Behav Date: 2013-09 Impact factor: 3.978
Authors: Priya Rajagopalan; Helga Refsum; Xue Hua; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson Journal: Neurobiol Aging Date: 2012-11-20 Impact factor: 4.673
Authors: Mario Siervo; Gilda Nasti; Blossom C M Stephan; Annamaria Papa; Edy Muscariello; Jonathan C K Wells; Carla M Prado; Antonio Colantuoni Journal: J Am Coll Nutr Date: 2012-04 Impact factor: 3.169
Authors: Kelly M Stanek; Gladys Strain; Michael Devlin; Ronald Cohen; Robert Paul; Ross D Crosby; James E Mitchell; John Gunstad Journal: Neuropsychology Date: 2013-03 Impact factor: 3.295
Authors: Marissa E Sakoda; Pariya L Fazeli; Ronald J Ellis; Dilip V Jeste; Igor Grant; Scott L Letendre; David J Moore Journal: J Acquir Immune Defic Syndr Date: 2017-03-01 Impact factor: 3.731